The upregulation of IGF2BP3 is associated with poor OS and an advanced stage of colon cancer, suggesting that IGF2BP3 can serve as a prognostic biomarker (Yang et al., 2020b). This evidence concerns the gene IGF2BP3 and colonic neoplasm.